Timp-3 deficiency impairs cognitive function in mice

Laboratory Investigation

Volumn 89, Issue 12, 2009, Pages 1340-1347

  Baba, Yoshichika ^a   Yasuda, Osamu ^a   Takemura, Yukihiro ^a   Ishikawa, Yasuyuki ^b   Ohishi, Mitsuru ^a   Iwanami, Jun ^c   Mogi, Masaki ^c   Doe, Nobutaka ^d   Horiuchi, Masatsugu ^c   Maeda, Nobuyo ^e   Fukuo, Keisuke ^f   Rakugi, Hiromi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Section of Behavioral Science   (Japan)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cognitive function; Extracellular matrix; Hippocampus; Matrix metalloproteinase; Timp 3

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ANIMALS; AVOIDANCE LEARNING; GELATINASES; HABITUATION, PSYCHOPHYSIOLOGIC; HIPPOCAMPUS; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 70549102493     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.101     Document Type: Article

References (38)

1. Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 2003;4:456-468.
2. Dityatev A, Schachner M. The extracellular matrix and synapses. Cell Tissue Res 2006;326:647-654.
3. Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol 2004;72:263-293.
4. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
5. Milward EA, Fitzsimmons C, Szklarczyk A, et al. The matrix metalloproteinases and CNS plasticity: an overview. J Neuroimmunol 2007;187:9-19.
6. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361.
7. Tsunemi K, Takai S, Nishimoto M, et al. Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. Hypertens Res 2002;25: 817-822.
8. Iwashima Y, Horio T, Kuroda S, et al. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res 2002;25:49-56.
9. Higuchi M, Yasuda O, Kawamoto H, et al. Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in mice. Hypertens Res 2007;30:563-571.
10. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-283.
11. Leco KJ, Khokha R, Pavloff N, et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994;269:9352-9360.
12. Fedak PW, Verma S, Weisel RD, et al. Cardiac remodeling and failure: from molecules to man (Part II). Cardiovasc Pathol 2005;14:49-60. (Pubitemid 40381300)
13. Lambert E, Dasse E, Haye B, et al. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004;49:187-198.
14. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573.
15. Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 2004;567:129-135.
16. Agrawal SM, Lau L, Yong VW. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008; 19:42-51.
17. Yong VW, Power C, Forsyth P, et al. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001;2: 502-511.
18. Yong VW, Krekoski CA, Forsyth PA, et al. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998;21:75-80.
19. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008;2:202-207.
20. Ulrich R, Baumgartner W, Gerhauser I, et al. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. J Neuropathol Exp Neurol 2006;65: 783-793.
21. Yong VW. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005;6:931-944.
22. Ethell IM, Ethell DW. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 2007;85:2813-2823.
23. Jourquin J, Tremblay E, Bernard A, et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur J Neurosci 2005;22: 2569-2578.
24. Chaillan FA, Rivera S, Marchetti E, et al. Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behav Brain Res 2006;173:191-198.
25. Jaworski DM, Boone J, Caterina J, et al. Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice. Brain Res 2005;1051:81-89.
26. Kawamoto H, Yasuda O, Suzuki T, et al. Tissue inhibitor of metalloproteinase-3 plays important roles in the kidney following unilateral ureteral obstruction. Hypertens Res 2006;29:285-294.
27. Amantea D, Corasaniti MT, Mercuri NB, et al. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion. Neuroscience 2008; 152:8-17.
28. Mook OR, Van Overbeek C, Ackema EG, et al. In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J Histochem Cytochem 2003;51:821-829.
29. Upchurch M, Wehner JM. Differences between inbred strains of mice in Morris water maze performance. Behav Genet 1988;18: 55-68.
30. Schuster T, Krug M, Stalder M, et al. Immunoelectron microscopic localization of the neural recognition molecules L1, NCAM, and its isoform NCAM180, the NCAM-associated polysialic acid, beta1 integrin and the extracellular matrix molecule tenascin-R in synapses of the adult rat hippocampus. J Neurobiol 2001;49:142-158.
31. Staubli U, Chun D, Lynch G. Time-dependent reversal of long-term potentiation by an integrin antagonist. J Neurosci 1998;18: 3460-3469.
32. Pagenstecher A, Stalder AK, Kincaid CL, et al. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998;152:729-741.
33. Jaworski DM, Fager N. Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development. J Neurosci Res 2000;61:396-408.
34. Li Z, Clarke MP, Barker MD, et al. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights. Expert Rev Mol Med 2005;7:1-15.
35. Langton KP, McKie N, Curtis A, et al. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem 2000;275:27027-27031.
36. Fariss RN, Apte SS, Luthert PJ, et al. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 1998;82:1329-1334.
37. Fedak PW, Smookler DS, Kassiri Z, et al. TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation 2004;110:2401-2409.
38. Leco KJ, Waterhouse P, Sanchez OH, et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 2001;108: 817-829.